FMT
CLVS

First Mercantile Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

First Mercantile Trust’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,985
Closed -$58K – 958
2018
Q3 		$58K Buy
1,985
+25
+1% +$968 0.01% 776
2018
Q2 		$89K Buy
1,960
+95
+5% +$4.62K 0.02% 741
2018
Q1 		$98K Buy
1,865
+185
+11% +$10.8K 0.02% 686
2017
Q4 		$114K Sell
1,680
-5,164
-75% -$361K 0.02% 686
2017
Q3 		$564K Buy
6,844
+2,647
+63% +$210K 0.1% 250
2017
Q2 		$393K Buy
4,197
+2,397
+133% +$147K 0.07% 352
2017
Q1 		$115K Buy
+1,800
New +$109K 0.02% 711
2015
Q4 		– Sell
-720
Closed -$66K – 988
2015
Q3 		$66K Buy
+720
New +$62.3K 0.01% 894

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

First Mercantile Trust's CLVS Position: Q4 2018 in Review

First Mercantile Trust sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 1,985 shares — an estimated $58K sold.

First Mercantile Trust first reported a position in CLVS in Q3 2015 and held it in 8 quarters. The position peaked at $564K in Q3 2017. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • First Mercantile Trust reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • First Mercantile Trust sold 1,985 Clovis Oncology, Inc. shares in Q4 2018, an estimated $58K.
  • First Mercantile Trust first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 8 quarters.
  • First Mercantile Trust's Clovis Oncology, Inc. position peaked at $564K in Q3 2017.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on First Mercantile Trust's 13F filing for Q4 2018, filed 1 Feb 2019.